{"transactions":[{"id":875181,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2026-03-02T22:59:46.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":11116,"price":77.15,"value":857599.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 26, 2026."}],"balance_after":101056,"source":{"system":"sec-edgar","filing":"0001870913-26-000005","document":"wk-form4_1772492383.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187091326000005/wk-form4_1772492383.xml","form_type":"4"}},{"id":905858,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2026-02-13T21:06:29.000Z","date":"2026-02-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":2898,"price":76.25,"value":220972.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 11,578 performance stock units, the grant of which was previously reported on April 6, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 250 shares of ANI Pharmaceuticals, Inc. Common Stock that were acquired under the ANI Pharmaceuticals, Inc. Employee Stock Purchase Plan in transactions that were exempt under Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":89940,"source":{"system":"sec-edgar","filing":"0001870913-26-000002","document":"wk-form4_1771016786.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187091326000002/wk-form4_1771016786.xml","form_type":"4"}},{"id":1058684,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2025-08-22T22:10:01.000Z","date":"2025-08-21","kind":"sale","planned":false,"acquired":false,"shares":52988,"price":90.44,"value":4792234.72,"ownership":{"direct":false,"nature":"Held by Esjay LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The shares were sold in multiple trades at prices ranging from $89.90 to $91.44. The price reported above reflects the weighted average sales price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reporting person holds voting and dispositive power over the shares held by Esjay LLC."}],"balance_after":431920,"source":{"system":"sec-edgar","filing":"0001870913-25-000008","document":"wk-form4_1755900596.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187091325000008/wk-form4_1755900596.xml","form_type":"4"}},{"id":1058683,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2025-08-22T22:10:01.000Z","date":"2025-08-20","kind":"sale","planned":false,"acquired":false,"shares":47012,"price":90.27,"value":4243773.24,"ownership":{"direct":false,"nature":"Held by Esjay LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were sold in multiple trades at prices ranging from $89.21 to $90.83. The price reported above reflects the weighted average sales price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reporting person holds voting and dispositive power over the shares held by Esjay LLC."}],"balance_after":484908,"source":{"system":"sec-edgar","filing":"0001870913-25-000008","document":"wk-form4_1755900596.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187091325000008/wk-form4_1755900596.xml","form_type":"4"}},{"id":1064497,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2025-08-18T20:32:05.000Z","date":"2025-08-15","kind":"sale","planned":false,"acquired":false,"shares":52990,"price":87.15,"value":4618078.5,"ownership":{"direct":false,"nature":"Held by Esjay LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The shares were sold in multiple trades at prices ranging from $85.44 to $90.00. The price reported above reflects the weighted average sales price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reporting person holds voting and dispositive power over the shares held by Esjay LLC."}],"balance_after":531920,"source":{"system":"sec-edgar","filing":"0001870913-25-000006","document":"wk-form4_1755549120.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187091325000006/wk-form4_1755549120.xml","form_type":"4"}},{"id":1064496,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2025-08-18T20:32:05.000Z","date":"2025-08-14","kind":"sale","planned":false,"acquired":false,"shares":47010,"price":89.48,"value":4206454.8,"ownership":{"direct":false,"nature":"Held by Esjay LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were sold in multiple trades at prices ranging from $88.20 to $90.11. The price reported above reflects the weighted average sales price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reporting person holds voting and dispositive power over the shares held by Esjay LLC."}],"balance_after":584910,"source":{"system":"sec-edgar","filing":"0001870913-25-000006","document":"wk-form4_1755549120.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187091325000006/wk-form4_1755549120.xml","form_type":"4"}},{"id":1151318,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2025-05-13T20:21:52.000Z","date":"2025-05-09","kind":"sale","planned":true,"acquired":false,"shares":700,"price":76.83,"value":53781.0,"ownership":{"direct":false,"nature":"Held by Esjay LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 18, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple trades at prices ranging from $76.11 to $76.95. The price reported above reflects the weighted average sales price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person holds voting and dispositive power over the shares held by Esjay LLC."}],"balance_after":631920,"source":{"system":"sec-edgar","filing":"0001870913-25-000004","document":"wk-form4_1747167705.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187091325000004/wk-form4_1747167705.xml","form_type":"4"}},{"id":1264828,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2025-02-19T01:19:58.000Z","date":"2025-02-12","kind":"grant","planned":false,"acquired":true,"shares":9574,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares represent performance stock units, which will vest over the applicable performance period based on the achievement of the provided performance targets, as set forth in the governing award agreement, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting."}],"balance_after":92588,"source":{"system":"sec-edgar","filing":"0001870913-25-000002","document":"wk-form4_1739927992.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187091325000002/wk-form4_1739927992.xml","form_type":"4"}},{"id":1264827,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2025-02-19T01:19:58.000Z","date":"2025-02-12","kind":"grant","planned":false,"acquired":true,"shares":14362,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 12, 2025."}],"balance_after":83014,"source":{"system":"sec-edgar","filing":"0001870913-25-000002","document":"wk-form4_1739927992.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187091325000002/wk-form4_1739927992.xml","form_type":"4"}},{"id":1451423,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2024-07-19T21:30:14.000Z","date":"2024-07-18","kind":"sale","planned":true,"acquired":false,"shares":2743,"price":62,"value":170066.0,"ownership":{"direct":false,"nature":"Held by Esjay LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple trades at prices ranging from $61.01 to $62.92. The price reported above reflects the weighted average sales price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person holds voting and dispositive power over the shares held by Esjay LLC."}],"balance_after":632620,"source":{"system":"sec-edgar","filing":"0001870913-24-000028","document":"wk-form4_1721424608.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187091324000028/wk-form4_1721424608.xml","form_type":"4"}},{"id":1453036,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2024-07-17T23:07:47.000Z","date":"2024-07-17","kind":"sale","planned":true,"acquired":false,"shares":14257,"price":63.16,"value":900472.12,"ownership":{"direct":false,"nature":"Held by Esjay LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The shares were sold in multiple trades at prices ranging from $62.62 to $64.21. The price reported above reflects the weighted average sales price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person holds voting and dispositive power over the shares held by Esjay LLC."}],"balance_after":635363,"source":{"system":"sec-edgar","filing":"0001870913-24-000026","document":"wk-form4_1721257659.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187091324000026/wk-form4_1721257659.xml","form_type":"4"}},{"id":1453035,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2024-07-17T23:07:47.000Z","date":"2024-07-16","kind":"sale","planned":true,"acquired":false,"shares":22000,"price":64.27,"value":1413940.0,"ownership":{"direct":false,"nature":"Held by Esjay LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The shares were sold in multiple trades at prices ranging from $63.25 to $64.91. The price reported above reflects the weighted average sales price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person holds voting and dispositive power over the shares held by Esjay LLC."}],"balance_after":649620,"source":{"system":"sec-edgar","filing":"0001870913-24-000026","document":"wk-form4_1721257659.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187091324000026/wk-form4_1721257659.xml","form_type":"4"}},{"id":1453034,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2024-07-17T23:07:47.000Z","date":"2024-07-15","kind":"sale","planned":true,"acquired":false,"shares":11000,"price":63.38,"value":697180.0,"ownership":{"direct":false,"nature":"Held by Esjay LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple trades at prices ranging from $62.47 to $64.19. The price reported above reflects the weighted average sales price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person holds voting and dispositive power over the shares held by Esjay LLC."}],"balance_after":671620,"source":{"system":"sec-edgar","filing":"0001870913-24-000026","document":"wk-form4_1721257659.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187091324000026/wk-form4_1721257659.xml","form_type":"4"}},{"id":1471210,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2024-06-24T20:12:03.000Z","date":"2024-06-21","kind":"sale","planned":true,"acquired":false,"shares":20000,"price":58.9,"value":1178000.0,"ownership":{"direct":false,"nature":"Held by Esjay LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple trades at prices ranging from $58.43 to $59.48. The price reported above reflects the weighted average sales price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person holds voting and dispositive power over the shares held by Esjay LLC."}],"balance_after":682620,"source":{"system":"sec-edgar","filing":"0001870913-24-000024","document":"wk-form4_1719259916.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187091324000024/wk-form4_1719259916.xml","form_type":"4"}},{"id":1473788,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2024-06-20T23:11:07.000Z","date":"2024-06-20","kind":"sale","planned":true,"acquired":false,"shares":11447,"price":59.86,"value":685217.42,"ownership":{"direct":false,"nature":"Held by Esjay LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The shares were sold in multiple trades at prices ranging from $59.40 to $60.50. The price reported above reflects the weighted average sales price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person holds voting and dispositive power over the shares held by Esjay LLC."}],"balance_after":702620,"source":{"system":"sec-edgar","filing":"0001870913-24-000022","document":"wk-form4_1718925060.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187091324000022/wk-form4_1718925060.xml","form_type":"4"}},{"id":1473787,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2024-06-20T23:11:07.000Z","date":"2024-06-18","kind":"sale","planned":true,"acquired":false,"shares":10607,"price":60.76,"value":644481.32,"ownership":{"direct":false,"nature":"Held by Esjay LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The shares were sold in multiple trades at prices ranging from $60.33 to $61.82. The price reported above reflects the weighted average sales price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person holds voting and dispositive power over the shares held by Esjay LLC."}],"balance_after":714067,"source":{"system":"sec-edgar","filing":"0001870913-24-000022","document":"wk-form4_1718925060.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187091324000022/wk-form4_1718925060.xml","form_type":"4"}},{"id":1473786,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2024-06-20T23:11:07.000Z","date":"2024-06-17","kind":"sale","planned":true,"acquired":false,"shares":7946,"price":61.41,"value":487963.86,"ownership":{"direct":false,"nature":"Held by Esjay LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple trades at prices ranging from $60.77 to $62.55. The price reported above reflects the weighted average sales price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person holds voting and dispositive power over the shares held by Esjay LLC."}],"balance_after":724674,"source":{"system":"sec-edgar","filing":"0001870913-24-000022","document":"wk-form4_1718925060.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187091324000022/wk-form4_1718925060.xml","form_type":"4"}},{"id":1507607,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2024-05-21T21:21:53.000Z","date":"2024-05-20","kind":"sale","planned":true,"acquired":false,"shares":12855,"price":61.81,"value":794567.55,"ownership":{"direct":false,"nature":"Held by Esjay LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple trades at prices ranging from $61.44 to $62.36. The price reported above reflects the weighted average sales price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person holds voting and dispositive power over the shares held by Esjay LLC."}],"balance_after":732620,"source":{"system":"sec-edgar","filing":"0001870913-24-000020","document":"wk-form4_1716326500.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187091324000020/wk-form4_1716326500.xml","form_type":"4"}},{"id":1512282,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2024-05-17T22:05:00.000Z","date":"2024-05-17","kind":"sale","planned":true,"acquired":false,"shares":5836,"price":62.09,"value":362357.24,"ownership":{"direct":false,"nature":"Held by Esjay LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The shares were sold in multiple trades at prices ranging from $61.43 to $64.00. The price reported above reflects the weighted average sales price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person holds voting and dispositive power over the shares held by Esjay LLC."}],"balance_after":745475,"source":{"system":"sec-edgar","filing":"0001870913-24-000018","document":"wk-form4_1715983489.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187091324000018/wk-form4_1715983489.xml","form_type":"4"}},{"id":1512281,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2024-05-17T22:05:00.000Z","date":"2024-05-16","kind":"sale","planned":true,"acquired":false,"shares":16459,"price":63.84,"value":1050742.56,"ownership":{"direct":false,"nature":"Held by Esjay LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The shares were sold in multiple trades at prices ranging from $63.28 to $64.90. The price reported above reflects the weighted average sales price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person holds voting and dispositive power over the shares held by Esjay LLC."}],"balance_after":751311,"source":{"system":"sec-edgar","filing":"0001870913-24-000018","document":"wk-form4_1715983489.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187091324000018/wk-form4_1715983489.xml","form_type":"4"}},{"id":1512280,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2024-05-17T22:05:00.000Z","date":"2024-05-15","kind":"sale","planned":true,"acquired":false,"shares":14850,"price":65.86,"value":978021.0,"ownership":{"direct":false,"nature":"Held by Esjay LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple trades at prices ranging from $64.66 to $66.54. The price reported above reflects the weighted average sales price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person holds voting and dispositive power over the shares held by Esjay LLC."}],"balance_after":767770,"source":{"system":"sec-edgar","filing":"0001870913-24-000018","document":"wk-form4_1715983489.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187091324000018/wk-form4_1715983489.xml","form_type":"4"}},{"id":1537956,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2024-04-22T22:26:41.000Z","date":"2024-04-19","kind":"sale","planned":true,"acquired":false,"shares":16809,"price":65.17,"value":1095442.53,"ownership":{"direct":false,"nature":"Held by Esjay LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The shares were sold in multiple trades at prices ranging from $64.20 to $65.79. The price reported above reflects the weighted average sales price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person holds voting and dispositive power over the shares held by Esjay LLC."}],"balance_after":782620,"source":{"system":"sec-edgar","filing":"0001870913-24-000016","document":"wk-form4_1713824793.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187091324000016/wk-form4_1713824793.xml","form_type":"4"}},{"id":1537955,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2024-04-22T22:26:41.000Z","date":"2024-04-18","kind":"sale","planned":true,"acquired":false,"shares":10423,"price":64.98,"value":677286.54,"ownership":{"direct":false,"nature":"Held by Esjay LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple trades at prices ranging from $64.43 to $65.89. The price reported above reflects the weighted average sales price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person holds voting and dispositive power over the shares held by Esjay LLC."}],"balance_after":799429,"source":{"system":"sec-edgar","filing":"0001870913-24-000016","document":"wk-form4_1713824793.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187091324000016/wk-form4_1713824793.xml","form_type":"4"}},{"id":1540426,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2024-04-17T20:33:11.000Z","date":"2024-04-17","kind":"sale","planned":true,"acquired":false,"shares":9520,"price":65.4,"value":622608.0,"ownership":{"direct":false,"nature":"Held by Esjay LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The shares were sold in multiple trades at prices ranging from $65.04 to $66.06. The price reported above reflects the weighted average sales price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person holds voting and dispositive power over the shares held by Esjay LLC."}],"balance_after":809852,"source":{"system":"sec-edgar","filing":"0001870913-24-000014","document":"wk-form4_1713385980.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187091324000014/wk-form4_1713385980.xml","form_type":"4"}},{"id":1540425,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2024-04-17T20:33:11.000Z","date":"2024-04-16","kind":"sale","planned":true,"acquired":false,"shares":5834,"price":66.2,"value":386210.8,"ownership":{"direct":false,"nature":"Held by Esjay LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The shares were sold in multiple trades at prices ranging from $66.01 to $66.58. The price reported above reflects the weighted average sales price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person holds voting and dispositive power over the shares held by Esjay LLC."}],"balance_after":819372,"source":{"system":"sec-edgar","filing":"0001870913-24-000014","document":"wk-form4_1713385980.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187091324000014/wk-form4_1713385980.xml","form_type":"4"}},{"id":1540424,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2024-04-17T20:33:11.000Z","date":"2024-04-15","kind":"sale","planned":true,"acquired":false,"shares":7414,"price":66.33,"value":491770.62,"ownership":{"direct":false,"nature":"Held by Esjay LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple trades at prices ranging from $65.65 to $67.27. The price reported above reflects the weighted average sales price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person holds voting and dispositive power over the shares held by Esjay LLC."}],"balance_after":825206,"source":{"system":"sec-edgar","filing":"0001870913-24-000014","document":"wk-form4_1713385980.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187091324000014/wk-form4_1713385980.xml","form_type":"4"}},{"id":1584868,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2024-03-11T22:43:20.000Z","date":"2024-03-08","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":67.17,"value":671700.0,"ownership":{"direct":false,"nature":"Held by Esjay LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $66.51 to $67.81, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person holds voting and dispositive power over the shares held by Esjay LLC."}],"balance_after":832620,"source":{"system":"sec-edgar","filing":"0001870913-24-000012","document":"wk-form4_1710196991.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187091324000012/wk-form4_1710196991.xml","form_type":"4"}},{"id":1589864,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2024-03-08T02:11:59.000Z","date":"2024-03-07","kind":"sale","planned":true,"acquired":false,"shares":15085,"price":66.35,"value":1000889.75,"ownership":{"direct":false,"nature":"Held by Esjay LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $65.53 to $67.00, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person holds voting and dispositive power over the shares held by Esjay LLC."}],"balance_after":842620,"source":{"system":"sec-edgar","filing":"0001870913-24-000010","document":"wk-form4_1709863910.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187091324000010/wk-form4_1709863910.xml","form_type":"4"}},{"id":1589863,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2024-03-08T02:11:59.000Z","date":"2024-03-06","kind":"sale","planned":true,"acquired":false,"shares":14822,"price":65.47,"value":970396.34,"ownership":{"direct":false,"nature":"Held by Esjay LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $64.84 to $66.04, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person holds voting and dispositive power over the shares held by Esjay LLC."}],"balance_after":857705,"source":{"system":"sec-edgar","filing":"0001870913-24-000010","document":"wk-form4_1709863910.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187091324000010/wk-form4_1709863910.xml","form_type":"4"}},{"id":1589862,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2024-03-08T02:11:59.000Z","date":"2024-03-05","kind":"sale","planned":true,"acquired":false,"shares":10093,"price":65.35,"value":659577.55,"ownership":{"direct":false,"nature":"Held by Esjay LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $64.45 to $66.58, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person holds voting and dispositive power over the shares held by Esjay LLC."}],"balance_after":872527,"source":{"system":"sec-edgar","filing":"0001870913-24-000010","document":"wk-form4_1709863910.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187091324000010/wk-form4_1709863910.xml","form_type":"4"}},{"id":1608054,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2024-03-01T22:18:27.000Z","date":"2024-02-29","kind":"tax_withholding","planned":false,"acquired":false,"shares":1122,"price":67.67,"value":75925.74,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 4,342 shares of restricted stock, the grant of which was previously reported."}],"balance_after":68652,"source":{"system":"sec-edgar","filing":"0001870913-24-000008","document":"wk-form4_1709331498.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187091324000008/wk-form4_1709331498.xml","form_type":"4"}},{"id":1639215,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2024-02-16T21:53:12.000Z","date":"2024-02-14","kind":"grant","planned":false,"acquired":true,"shares":8946,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares represent performance stock units, which will vest over the applicable performance period based on the achievement of the provided performance targets, as set forth in the governing award agreement, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting."}],"balance_after":69774,"source":{"system":"sec-edgar","filing":"0001870913-24-000006","document":"wk-form4_1708120376.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187091324000006/wk-form4_1708120376.xml","form_type":"4"}},{"id":1639214,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2024-02-16T21:53:12.000Z","date":"2024-02-14","kind":"grant","planned":false,"acquired":true,"shares":13421,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 14, 2024."}],"balance_after":60828,"source":{"system":"sec-edgar","filing":"0001870913-24-000006","document":"wk-form4_1708120376.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187091324000006/wk-form4_1708120376.xml","form_type":"4"}},{"id":1673456,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2024-01-23T22:32:18.000Z","date":"2024-01-23","kind":"sale","planned":true,"acquired":false,"shares":15000,"price":56.44,"value":846600.0,"ownership":{"direct":false,"nature":"Held by Esjay LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $56.00 to $57.11, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person holds voting and dispositive power over the shares held by Esjay LLC."}],"balance_after":882620,"source":{"system":"sec-edgar","filing":"0001870913-24-000004","document":"wk-form4_1706049128.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187091324000004/wk-form4_1706049128.xml","form_type":"4"}},{"id":1673455,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2024-01-23T22:32:18.000Z","date":"2024-01-22","kind":"sale","planned":true,"acquired":false,"shares":5692,"price":55.95,"value":318467.4,"ownership":{"direct":false,"nature":"Held by Esjay LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $55.63 to $56.21, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person holds voting and dispositive power over the shares held by Esjay LLC."}],"balance_after":897620,"source":{"system":"sec-edgar","filing":"0001870913-24-000004","document":"wk-form4_1706049128.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187091324000004/wk-form4_1706049128.xml","form_type":"4"}},{"id":1673454,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2024-01-23T22:32:18.000Z","date":"2024-01-19","kind":"sale","planned":true,"acquired":false,"shares":4524,"price":55.57,"value":251398.68,"ownership":{"direct":false,"nature":"Held by Esjay LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $55.03 to $56.00, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person holds voting and dispositive power over the shares held by Esjay LLC."}],"balance_after":903312,"source":{"system":"sec-edgar","filing":"0001870913-24-000004","document":"wk-form4_1706049128.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187091324000004/wk-form4_1706049128.xml","form_type":"4"}},{"id":1676989,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2024-01-18T23:20:10.000Z","date":"2024-01-18","kind":"sale","planned":true,"acquired":false,"shares":9784,"price":55.3,"value":541055.2,"ownership":{"direct":false,"nature":"Held by Esjay LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $54.70 to $55.73, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person holds voting and dispositive power over the shares held by Esjay LLC."}],"balance_after":907836,"source":{"system":"sec-edgar","filing":"0001870913-24-000002","document":"wk-form4_1705619998.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187091324000002/wk-form4_1705619998.xml","form_type":"4"}},{"id":1676988,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2024-01-18T23:20:10.000Z","date":"2024-01-17","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":55.11,"value":551100.0,"ownership":{"direct":false,"nature":"Held by Esjay LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $54.59 to $55.57, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person holds voting and dispositive power over the shares held by Esjay LLC."}],"balance_after":917620,"source":{"system":"sec-edgar","filing":"0001870913-24-000002","document":"wk-form4_1705619998.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187091324000002/wk-form4_1705619998.xml","form_type":"4"}},{"id":1676987,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2024-01-18T23:20:10.000Z","date":"2024-01-16","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":55.63,"value":278150.0,"ownership":{"direct":false,"nature":"Held by Esjay LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $54.99 to $56.71, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person holds voting and dispositive power over the shares held by Esjay LLC."}],"balance_after":927620,"source":{"system":"sec-edgar","filing":"0001870913-24-000002","document":"wk-form4_1705619998.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187091324000002/wk-form4_1705619998.xml","form_type":"4"}},{"id":1705699,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2023-12-19T22:44:21.000Z","date":"2023-12-19","kind":"sale","planned":true,"acquired":false,"shares":25000,"price":52.65,"value":1316250.0,"ownership":{"direct":false,"nature":"Held by Esjay LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $52.45 to $53.19, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person holds voting and dispositive power over the shares held by Esjay LLC."}],"balance_after":932620,"source":{"system":"sec-edgar","filing":"0001870913-23-000020","document":"wk-form4_1703025852.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187091323000020/wk-form4_1703025852.xml","form_type":"4"}},{"id":1705698,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2023-12-19T22:44:21.000Z","date":"2023-12-18","kind":"sale","planned":true,"acquired":false,"shares":13026,"price":52.44,"value":683083.44,"ownership":{"direct":false,"nature":"Held by Esjay LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $52.02 to $52.97, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person holds voting and dispositive power over the shares held by Esjay LLC."}],"balance_after":957620,"source":{"system":"sec-edgar","filing":"0001870913-23-000020","document":"wk-form4_1703025852.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187091323000020/wk-form4_1703025852.xml","form_type":"4"}},{"id":1705697,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2023-12-19T22:44:21.000Z","date":"2023-12-15","kind":"sale","planned":true,"acquired":false,"shares":11974,"price":52.44,"value":627916.56,"ownership":{"direct":false,"nature":"Held by Esjay LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $51.97 to $52.97, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person holds voting and dispositive power over the shares held by Esjay LLC."}],"balance_after":970646,"source":{"system":"sec-edgar","filing":"0001870913-23-000020","document":"wk-form4_1703025852.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187091323000020/wk-form4_1703025852.xml","form_type":"4"}},{"id":1735155,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2023-11-21T02:05:59.000Z","date":"2023-11-17","kind":"sale","planned":true,"acquired":false,"shares":13000,"price":51,"value":663000.0,"ownership":{"direct":false,"nature":"Held by Esjay LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $50.70 to $51.43, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person holds voting and dispositive power over the shares held by Esjay LLC."}],"balance_after":982620,"source":{"system":"sec-edgar","filing":"0001870913-23-000018","document":"wk-form4_1700532348.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187091323000018/wk-form4_1700532348.xml","form_type":"4"}},{"id":1735153,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2023-11-21T01:58:10.000Z","date":"2023-11-16","kind":"sale","planned":true,"acquired":false,"shares":6448,"price":51.66,"value":333103.68,"ownership":{"direct":false,"nature":"Held by Esjay LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $51.14 to $52.70, inclusive"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person holds voting and dispositive power over the shares held by Esjay LLC."}],"balance_after":995620,"source":{"system":"sec-edgar","filing":"0001870913-23-000016","document":"wk-form4a_1700531880.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187091323000016/wk-form4a_1700531880.xml","form_type":"4/A","original_submission_date":"2023-11-16"}},{"id":1735152,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2023-11-21T01:58:10.000Z","date":"2023-11-15","kind":"sale","planned":true,"acquired":false,"shares":7647,"price":53.64,"value":410185.08,"ownership":{"direct":false,"nature":"Held by Esjay LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $52.96 to $54.24, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person holds voting and dispositive power over the shares held by Esjay LLC."}],"balance_after":1002068,"source":{"system":"sec-edgar","filing":"0001870913-23-000016","document":"wk-form4a_1700531880.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187091323000016/wk-form4a_1700531880.xml","form_type":"4/A","original_submission_date":"2023-11-16"}},{"id":1735151,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2023-11-21T01:58:10.000Z","date":"2023-11-14","kind":"sale","planned":true,"acquired":false,"shares":22905,"price":53.17,"value":1217858.85,"ownership":{"direct":false,"nature":"Held by Esjay LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $51.95 to $54.07, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person holds voting and dispositive power over the shares held by Esjay LLC."}],"balance_after":1009715,"source":{"system":"sec-edgar","filing":"0001870913-23-000016","document":"wk-form4a_1700531880.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187091323000016/wk-form4a_1700531880.xml","form_type":"4/A","original_submission_date":"2023-11-16"}},{"id":1739617,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2023-11-16T23:11:17.000Z","date":"2023-11-16","kind":"sale","planned":true,"acquired":false,"shares":6448,"price":51.66,"value":333103.68,"ownership":{"direct":false,"nature":"Held by Esjay LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $51.14 to $52.70, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person holds voting and dispositive power over the shares held by Esjay LLC."}],"balance_after":996430,"source":{"system":"sec-edgar","filing":"0001870913-23-000013","document":"wk-form4_1700176267.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187091323000013/wk-form4_1700176267.xml","form_type":"4"}},{"id":1739616,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2023-11-16T23:11:17.000Z","date":"2023-11-15","kind":"sale","planned":true,"acquired":false,"shares":7647,"price":53.64,"value":410185.08,"ownership":{"direct":false,"nature":"Held by Esjay LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $52.96 to $54.24, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person holds voting and dispositive power over the shares held by Esjay LLC."}],"balance_after":1002878,"source":{"system":"sec-edgar","filing":"0001870913-23-000013","document":"wk-form4_1700176267.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187091323000013/wk-form4_1700176267.xml","form_type":"4"}},{"id":1739615,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2023-11-16T23:11:17.000Z","date":"2023-11-14","kind":"sale","planned":true,"acquired":false,"shares":22095,"price":53.17,"value":1174791.15,"ownership":{"direct":false,"nature":"Held by Esjay LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $51.95 to $54.07, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person holds voting and dispositive power over the shares held by Esjay LLC."}],"balance_after":1010525,"source":{"system":"sec-edgar","filing":"0001870913-23-000013","document":"wk-form4_1700176267.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187091323000013/wk-form4_1700176267.xml","form_type":"4"}},{"id":1757642,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2023-10-19T20:28:35.000Z","date":"2023-10-19","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":57.06,"value":570600.0,"ownership":{"direct":false,"nature":"Held by Esjay LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $56.50 to $57.69, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person holds voting and dispositive power over the shares held by Esjay LLC."}],"balance_after":1032620,"source":{"system":"sec-edgar","filing":"0001870913-23-000011","document":"wk-form4_1697747306.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187091323000011/wk-form4_1697747306.xml","form_type":"4"}},{"id":1757641,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2023-10-19T20:28:35.000Z","date":"2023-10-18","kind":"sale","planned":true,"acquired":false,"shares":6242,"price":57.78,"value":360662.76,"ownership":{"direct":false,"nature":"Held by Esjay LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $57.15 to $58.41, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person holds voting and dispositive power over the shares held by Esjay LLC."}],"balance_after":1042620,"source":{"system":"sec-edgar","filing":"0001870913-23-000011","document":"wk-form4_1697747306.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187091323000011/wk-form4_1697747306.xml","form_type":"4"}},{"id":1757640,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2023-10-19T20:28:35.000Z","date":"2023-10-17","kind":"sale","planned":true,"acquired":false,"shares":8758,"price":58.53,"value":512605.74,"ownership":{"direct":false,"nature":"Held by Esjay LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $58.03 to $59.47, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person holds voting and dispositive power over the shares held by Esjay LLC."}],"balance_after":1048862,"source":{"system":"sec-edgar","filing":"0001870913-23-000011","document":"wk-form4_1697747306.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187091323000011/wk-form4_1697747306.xml","form_type":"4"}},{"id":1759238,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2023-10-17T20:32:09.000Z","date":"2023-10-16","kind":"sale","planned":true,"acquired":false,"shares":13063,"price":58.31,"value":761703.53,"ownership":{"direct":false,"nature":"Held by Esjay LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $57.75 to $58.88, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person holds voting and dispositive power over the shares held by Esjay LLC."}],"balance_after":1057620,"source":{"system":"sec-edgar","filing":"0001870913-23-000009","document":"wk-form4_1697574720.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187091323000009/wk-form4_1697574720.xml","form_type":"4"}},{"id":1759237,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2023-10-17T20:32:09.000Z","date":"2023-10-13","kind":"sale","planned":true,"acquired":false,"shares":11937,"price":57.58,"value":687332.46,"ownership":{"direct":false,"nature":"Held by Esjay LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $57.36 to $58.00, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person holds voting and dispositive power over the shares held by Esjay LLC."}],"balance_after":1070683,"source":{"system":"sec-edgar","filing":"0001870913-23-000009","document":"wk-form4_1697574720.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187091323000009/wk-form4_1697574720.xml","form_type":"4"}},{"id":1778011,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2023-09-19T21:14:55.000Z","date":"2023-09-19","kind":"sale","planned":true,"acquired":false,"shares":25333,"price":61.23,"value":1551139.59,"ownership":{"direct":false,"nature":"Held by Esjay LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $60.63 to $61.69, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person holds voting and dispositive power over the shares held by Esjay LLC."}],"balance_after":1082620,"source":{"system":"sec-edgar","filing":"0001870913-23-000007","document":"wk-form4_1695158086.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187091323000007/wk-form4_1695158086.xml","form_type":"4"}},{"id":1778010,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2023-09-19T21:14:55.000Z","date":"2023-09-18","kind":"sale","planned":true,"acquired":false,"shares":8425,"price":61.64,"value":519317.0,"ownership":{"direct":false,"nature":"Held by Esjay LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $61.23 to $62.94, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person holds voting and dispositive power over the shares held by Esjay LLC."}],"balance_after":1107953,"source":{"system":"sec-edgar","filing":"0001870913-23-000007","document":"wk-form4_1695158086.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187091323000007/wk-form4_1695158086.xml","form_type":"4"}},{"id":1778009,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2023-09-19T21:14:55.000Z","date":"2023-09-15","kind":"sale","planned":true,"acquired":false,"shares":16242,"price":62.81,"value":1020160.02,"ownership":{"direct":false,"nature":"Held by Esjay LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $62.01 to $63.82, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person holds voting and dispositive power over the shares held by Esjay LLC."}],"balance_after":1116378,"source":{"system":"sec-edgar","filing":"0001870913-23-000007","document":"wk-form4_1695158086.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187091323000007/wk-form4_1695158086.xml","form_type":"4"}},{"id":1793337,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2023-08-30T20:29:01.000Z","date":"2023-08-29","kind":"sale","planned":false,"acquired":false,"shares":25000,"price":63.37,"value":1584250.0,"ownership":{"direct":false,"nature":"Held by Esjay LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the weighted average price of sales on August 29, 2023. The shares were sold in multiple transactions at prices ranging from $62.4877 to $63.92, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reporting person holds voting and dispositive power over the shares held by Esjay LLC."}],"balance_after":1132620,"source":{"system":"sec-edgar","filing":"0001870913-23-000005","document":"wk-form4_1693427333.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187091323000005/wk-form4_1693427333.xml","form_type":"4"}},{"id":1793336,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2023-08-30T20:29:01.000Z","date":"2023-08-28","kind":"sale","planned":false,"acquired":false,"shares":25000,"price":63.06,"value":1576500.0,"ownership":{"direct":false,"nature":"Held by Esjay LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the weighted average price of sales on August 28, 2023. The shares were sold in multiple transactions at prices ranging from $62.57 to $64.64, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reporting person holds voting and dispositive power over the shares held by Esjay LLC."}],"balance_after":1157620,"source":{"system":"sec-edgar","filing":"0001870913-23-000005","document":"wk-form4_1693427333.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187091323000005/wk-form4_1693427333.xml","form_type":"4"}},{"id":1806386,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2023-08-16T23:07:03.000Z","date":"2023-08-15","kind":"sale","planned":true,"acquired":false,"shares":22110,"price":61.6,"value":1361976.0,"ownership":{"direct":false,"nature":"Held by Esjay LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $60.81 to $62.59, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person holds voting and dispositive power over the shares held by Esjay LLC."}],"balance_after":1182620,"source":{"system":"sec-edgar","filing":"0001870913-23-000003","document":"wk-form4_1692227210.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187091323000003/wk-form4_1692227210.xml","form_type":"4"}},{"id":1806385,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2023-08-16T23:07:03.000Z","date":"2023-08-14","kind":"sale","planned":true,"acquired":false,"shares":27890,"price":61.15,"value":1705473.5,"ownership":{"direct":false,"nature":"Held by Esjay LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $60.12 to $62.58, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person holds voting and dispositive power over the shares held by Esjay LLC."}],"balance_after":1204730,"source":{"system":"sec-edgar","filing":"0001870913-23-000003","document":"wk-form4_1692227210.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000187091323000003/wk-form4_1692227210.xml","form_type":"4"}},{"id":1825116,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2023-07-21T23:15:47.000Z","date":"2023-07-21","kind":"sale","planned":true,"acquired":false,"shares":11500,"price":52.56,"value":604440.0,"ownership":{"direct":false,"nature":"Held by Esjay LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $52.10 to $53.32, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person holds voting and dispositive power over the shares held by Esjay LLC."}],"balance_after":1232620,"source":{"system":"sec-edgar","filing":"0001104659-23-083131","document":"tm2321830-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000110465923083131/tm2321830-1_4seq1.xml","form_type":"4"}},{"id":1825115,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2023-07-21T23:15:47.000Z","date":"2023-07-20","kind":"sale","planned":true,"acquired":false,"shares":6000,"price":51.52,"value":309120.0,"ownership":{"direct":false,"nature":"Held by Esjay LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $51.00 to $52.08, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person holds voting and dispositive power over the shares held by Esjay LLC."}],"balance_after":1244120,"source":{"system":"sec-edgar","filing":"0001104659-23-083131","document":"tm2321830-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000110465923083131/tm2321830-1_4seq1.xml","form_type":"4"}},{"id":1825114,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2023-07-21T23:15:47.000Z","date":"2023-07-19","kind":"sale","planned":true,"acquired":false,"shares":5969,"price":51.48,"value":307284.12,"ownership":{"direct":false,"nature":"Held by Esjay LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $50.95 to $52.28, inclusive. The reporting person undertakes to provide to ANI Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2, 4 and 5 to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person holds voting and dispositive power over the shares held by Esjay LLC."}],"balance_after":1250120,"source":{"system":"sec-edgar","filing":"0001104659-23-083131","document":"tm2321830-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000110465923083131/tm2321830-1_4seq1.xml","form_type":"4"}},{"id":1828127,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2023-07-19T00:06:26.000Z","date":"2023-07-18","kind":"sale","planned":true,"acquired":false,"shares":6700,"price":51.84,"value":347328.0,"ownership":{"direct":false,"nature":"Held by Esjay LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $51.62 to $52.38, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person holds voting and dispositive power over the shares held by Esjay LLC."}],"balance_after":1256089,"source":{"system":"sec-edgar","filing":"0001104659-23-082112","document":"tm2321566-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000110465923082112/tm2321566-1_4seq1.xml","form_type":"4"}},{"id":1828126,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2023-07-19T00:06:26.000Z","date":"2023-07-17","kind":"sale","planned":true,"acquired":false,"shares":9831,"price":51.06,"value":501970.86,"ownership":{"direct":false,"nature":"Held by Esjay LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $49.77 to $51.66, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person holds voting and dispositive power over the shares held by Esjay LLC."}],"balance_after":1262789,"source":{"system":"sec-edgar","filing":"0001104659-23-082112","document":"tm2321566-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000110465923082112/tm2321566-1_4seq1.xml","form_type":"4"}},{"id":1828125,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2023-07-19T00:06:26.000Z","date":"2023-07-14","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":50.43,"value":504300.0,"ownership":{"direct":false,"nature":"Held by Esjay LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $49.98 to $50.83, inclusive. The reporting person undertakes to provide to ANI Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2,4 and 5 to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person holds voting and dispositive power over the shares held by Esjay LLC."}],"balance_after":1272620,"source":{"system":"sec-edgar","filing":"0001104659-23-082112","document":"tm2321566-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000110465923082112/tm2321566-1_4seq1.xml","form_type":"4"}},{"id":1845658,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2023-06-24T00:01:27.000Z","date":"2023-06-23","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":51.49,"value":514900.0,"ownership":{"direct":false,"nature":"Held by Esjay LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $50.99 to $52.08, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person holds voting and dispositive power over the shares held by Esjay LLC."}],"balance_after":1282620,"source":{"system":"sec-edgar","filing":"0001104659-23-074399","document":"tm2319615-2_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000110465923074399/tm2319615-2_4aseq1.xml","form_type":"4/A","original_submission_date":"2023-06-22"}},{"id":1845657,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2023-06-24T00:01:27.000Z","date":"2023-06-22","kind":"sale","planned":true,"acquired":false,"shares":13500,"price":51.38,"value":693630.0,"ownership":{"direct":false,"nature":"Held by Esjay LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $50.85 to $51.84, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person holds voting and dispositive power over the shares held by Esjay LLC."}],"balance_after":1292620,"source":{"system":"sec-edgar","filing":"0001104659-23-074399","document":"tm2319615-2_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000110465923074399/tm2319615-2_4aseq1.xml","form_type":"4/A","original_submission_date":"2023-06-22"}},{"id":1845656,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2023-06-24T00:01:27.000Z","date":"2023-06-21","kind":"sale","planned":true,"acquired":false,"shares":11843,"price":51.95,"value":615243.85,"ownership":{"direct":false,"nature":"Held by Esjay LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $51.13 to $52.56, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person holds voting and dispositive power over the shares held by Esjay LLC."}],"balance_after":1306120,"source":{"system":"sec-edgar","filing":"0001104659-23-074399","document":"tm2319615-2_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000110465923074399/tm2319615-2_4aseq1.xml","form_type":"4/A","original_submission_date":"2023-06-22"}},{"id":1845655,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2023-06-24T00:01:27.000Z","date":"2023-06-20","kind":"sale","planned":true,"acquired":false,"shares":14657,"price":51.93,"value":761138.01,"ownership":{"direct":false,"nature":"Held by Esjay LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $50.63 to $52.80, inclusive. The reporting person undertakes to provide to ANIPharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2, 4, 5 and 6 to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person holds voting and dispositive power over the shares held by Esjay LLC."}],"balance_after":1317963,"source":{"system":"sec-edgar","filing":"0001104659-23-074399","document":"tm2319615-2_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000110465923074399/tm2319615-2_4aseq1.xml","form_type":"4/A","original_submission_date":"2023-06-22"}},{"id":1846921,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2023-06-23T00:00:12.000Z","date":"2023-06-22","kind":"sale","planned":true,"acquired":false,"shares":13500,"price":51.38,"value":693630.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $50.85 to $51.84, inclusive."}],"balance_after":7407,"source":{"system":"sec-edgar","filing":"0001104659-23-073894","document":"tm2319370-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000110465923073894/tm2319370-1_4seq1.xml","form_type":"4"}},{"id":1846920,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2023-06-23T00:00:12.000Z","date":"2023-06-21","kind":"sale","planned":true,"acquired":false,"shares":11843,"price":51.95,"value":615243.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $51.13 to $52.56, inclusive."}],"balance_after":20907,"source":{"system":"sec-edgar","filing":"0001104659-23-073894","document":"tm2319370-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000110465923073894/tm2319370-1_4seq1.xml","form_type":"4"}},{"id":1846919,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2023-06-23T00:00:12.000Z","date":"2023-06-20","kind":"sale","planned":true,"acquired":false,"shares":14657,"price":51.93,"value":761138.01,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $50.63 to $52.80, inclusive. The reporting person undertakes to provide to ANI Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2, 3 and 4 to this Form 4."}],"balance_after":32750,"source":{"system":"sec-edgar","filing":"0001104659-23-073894","document":"tm2319370-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000110465923073894/tm2319370-1_4seq1.xml","form_type":"4"}},{"id":1929767,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2023-04-05T00:08:40.000Z","date":"2023-02-28","kind":"grant","planned":false,"acquired":true,"shares":11578,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares represent performance stock units, which will vest over the applicable performance period based on the achievement of the provided performance targets, as set forth in the governing award agreement, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting."}],"balance_after":47407,"source":{"system":"sec-edgar","filing":"0001104659-23-041740","document":"tm2311710-8_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000110465923041740/tm2311710-8_4seq1.xml","form_type":"4"}},{"id":1929766,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2023-04-05T00:08:40.000Z","date":"2023-02-28","kind":"grant","planned":false,"acquired":true,"shares":17369,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 28, 2023."}],"balance_after":35829,"source":{"system":"sec-edgar","filing":"0001104659-23-041740","document":"tm2311710-8_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000110465923041740/tm2311710-8_4seq1.xml","form_type":"4"}},{"id":2323496,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2022-03-22T01:58:12.000Z","date":"2022-03-17","kind":"purchase","acquired":true,"shares":5000,"price":27.6503,"value":138251.5,"ownership":{"direct":false,"nature":"Held by SS Pharma LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were acquired in multiple trades at prices ranging from $27.36 to $28.00. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person holds voting and dispositive power over the shares held by SS Pharma LLC."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001415889-22-003247","document":"form4-03212022_060303.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000141588922003247/form4-03212022_060303.xml","form_type":"4"}},{"id":2323495,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2022-03-22T01:58:12.000Z","date":"2022-03-17","kind":"purchase","acquired":true,"shares":5000,"price":27.6503,"value":138251.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were acquired in multiple trades at prices ranging from $27.36 to $28.00. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":18460,"source":{"system":"sec-edgar","filing":"0001415889-22-003247","document":"form4-03212022_060303.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000141588922003247/form4-03212022_060303.xml","form_type":"4"}},{"id":2499181,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2021-11-23T21:46:30.000Z","date":"2021-11-19","kind":"grant","acquired":true,"shares":1332620,"ownership":{"direct":false,"nature":"Held by Esjay LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the Merger Agreement, an aggregate of 6,954,750 Company Interests of Novitium held by Esjay LLC were converted into 1,332,620 shares of Common Stock of the Issuer. The issuance of the shares was approved by the Issuer's board of directors pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person holds voting and dispositive power over the shares held by Esjay LLC."}],"balance_after":1332620,"source":{"system":"sec-edgar","filing":"0001415889-21-005444","document":"form4-11232021_011120.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000141588921005444/form4-11232021_011120.xml","form_type":"4"}},{"id":2499180,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":64060,"kind":"person","name":"Shanmugam Muthusamy","position":1,"cik":"0001870913","reported_name":"Shanmugam Muthusamy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D, COO-NOVITIUM OPS"}}],"security":"Common Stock","published_at":"2021-11-23T21:46:30.000Z","date":"2021-11-19","kind":"grant","acquired":true,"shares":13460,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 19, 2021, pursuant to that certain Agreement and Plan of Merger, dated as of March 8, 2021 (as amended, supplemented or modified from time to time, the \"Merger Agreement\"), by and among ANI Pharmaceuticals, Inc., a Delaware corporation (the \"Issuer\"), Novitium Pharma LLC, a Delaware limited liability company (\"Novitium\"), and the other parties thereto, the Issuer completed its acquisition of Novitium.  In accordance with the Merger Agreement, an aggregate of 70,250 Company Interests of Novitium held by the Reporting Person were converted into 13,460 shares of Common Stock of the Issuer. The issuance of the shares was approved by the Issuer's board of directors pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended."}],"balance_after":13460,"source":{"system":"sec-edgar","filing":"0001415889-21-005444","document":"form4-11232021_011120.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000141588921005444/form4-11232021_011120.xml","form_type":"4"}}]}